How Biden’s Covid case compares to Trump’s
Today Headline,
Vaccines The key difference between Trump’s infection — which landed him in Walter Reed Military Medical Center for three…
How Biden’s Covid case compares to Trump's
Politico Magazine ,
Biden, who is twice boosted and has already started Paxlovid, is experiencing mild symptoms, according to the White House.
How does Biden’s case of Covid-19 compare to Trump’s?
DNYUZ,
President Joe Biden on Thursday tested positive for Covid-19, but his infection, while potentially serious, does not put him at…
How does Biden’s case of Covid-19 compare to Trump’s?
MSN,
President Joe Biden on Thursday tested positive for Covid-19, but his infection, while potentially serious, does not put him at…
How does Biden’s Covid-19 case compare to Trump’s?
Eminetra,
Vaccines Experts say the main difference between Trump’s infection — which landed him at Walter Reed Military Medical Center…
How does Biden's case of Covid-19 compare to Trump's?
Daily Magazine,
President Joe Biden on Thursday tested positive for Covid-19, but his infection, while potentially serious, does not put him at…
How does Biden’s case of Covid-19 compare to Trump’s?
Yahoo! News,
President Joe Biden on Thursday tested positive for Covid-19, but his infection, while potentially serious, does not put him at…
How does Biden’s case of Covid-19 compare to Trump’s?
Newsbreak,
President Joe Biden on Thursday tested positive for Covid-19, but his infection, while potentially serious, does not put him at…
News story from Stat News on Monday 13 June 2022
Stat News,
Ready or not, here it comes: We are unprepared for long COVID
MSN,
The recent disclosure by Sen. Tim Kaine (D-Va.) that he still suffers from COVID-19 symptoms nearly two years after being…
Ready or not, here it comes: We are unprepared for long COVID
Newsbreak,
The recent disclosure by Sen. Tim Kaine (D-Va.) that he still suffers from COVID-19 symptoms nearly two years after being…
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial
The Lancet,
BackgroundThere are few evidence-based interventions for long COVID; however, holistic approaches supporting recovery are…
The threat of long COVID means we can’t pull punches on vaccines, tests, and masks
Newsbreak,
Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most…
Long Covid: the invisible public health crisis fuelling labour shortages
Today UK News,
When Katie Lazell-Fairman returned to work after recovering from a Covid-19 infection, she quickly discovered that the virus…
Long Covid: the invisible public health crisis fuelling labour shortages
Tech Register,
When Katie Lazell-Fairman returned to work after recovering from a Covid-19 infection, she quickly discovered that the virus…
Long Covid: the invisible public health crisis fuelling labour shortages
Business Telegraph,
When Katie Lazell-Fairman returned to work after recovering from a Covid-19 infection, she quickly discovered that the virus…
Long Covid: the invisible public health crisis fuelling labour shortages
BusinessFast,
When Katie Lazell-Fairman returned to work after recovering from a Covid-19 infection, she quickly discovered that the virus…
When The Public Health Emergency Ends: What Will It Mean For Dually Eligible Individuals?
Health Affairs,
In response to the COVID-19 public health emergency (PHE), states have used a variety of federal policy flexibilities to…
We can do better than what was ‘normal’ before the pandemic
Science News,
It’s a weird time in the pandemic. COVID-19 cases are once again climbing in some parts of the United States, but still falling…
No debemos celebrar que el tapabocas no sea obligatorio
El Espectador,
En respuesta al editorial del 25 de febrero de 2022, titulado “No más tapabocas, pero continúa la cautela”.
MIL-OSI USA: Long COVID Leaves Newly Disabled People Facing Old Barriers
Foreign Affairs New Zealand,
Source: US State of Connecticut Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul…
Long COVID Leaves Newly Disabled People Facing Old Barriers
Mirage News,
Negative attitudes toward people with significant disabilities are common among health care providers, affecting the ability of…
2022, el año de la covid persistente: la carrera para buscar una cura específica
NIUS,
Tras dos años de pandemia y millones de afectados, los médicos creen que hay que apostar por encontrar un tratamiento específico…
Long COVID: disabilitas baru yang sulit mendapatkan perlakuan layak
The Conversation,
Sekitar sepertiga dari penyintas COVID-19 akan mengalami kondisi yang dikenal sebagai long atau long-haul COVID-19.
Long COVID Leaves Newly Disabled People Facing Old Barriers – A Sociologist Explains
Medical Daily,
Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Deux ans après le début de la pandémie, le coronavirus continue de surprendre les experts
National Geographic,
Les pathogènes, RaulAndino les connaît bien. Depuis plus de trente ans, le chercheur de l’Université de Californie étudie les…
Two years later, coronavirus evolution still surprises experts. Here’s why.
NationalGeographic.co.uk,
Raul Andino knows his pathogens. For more than 30 years the University of California, San Francisco researcher has studied RNA…
Long COVID Leaves Newly Disabled People Facing Old Barriers – a Sociologist Explains
Government Executive,
As COVID-19 survivors join the ranks of people with disabilities, they could have a long wait to get the support they need.
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
KRQE,
(THE CONVERSATION) Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Long COVID leaves newly disabled people facing old barriers
Kiowa County Press ,
Some COVID-19 patients experience months of debilitating symptoms. sharply_done/E+ via Laura Mauldin, University of Connecticut…
Two years later, coronavirus evolution still surprises experts. Here’s why.
National Geographic,
Science Coronavirus Coverage Scientists and physicians continue to be amazed by how quickly the virus evolves, what it does to…
Long COVID leaves newly disabled people facing old barriers. A sociologist explains
MedicalXpress,
Credit: Unsplash/CC0 Public Domain Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul…
Long COVID Leaves Newly Disabled People Facing Old Barriers – a Sociologist Explains
Hareetz ,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Fox News 26,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Columbus Telegram,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
St. Louis Post-Dispatch,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Idaho Press,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
The Buffalo News,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers a sociologist explains
Arizona Daily Star,
Long COVID leaves newly disabled people facing old barriers – a sociologist explains (The Conversation is an independent and…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Lincoln Journal Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Dispatch-Argus,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
The Bismarck Tribune,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
goskagit.com,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Yahoo! News,
Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Long COVID leaves newly disabled people facing old barriers - a sociologist explains
Daily Magazine,
Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
The Darien Times,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Global Advisors,
Some COVID-19 patients experience months of debilitating symptoms. sharply_done/E+ via Up to one-third of COVID-19 survivors…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
San Antonio Express-News,
(THE CONVERSATION) Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
New Canaan Advertiser,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Bozeman Daily Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) I am a…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laura Mauldin…
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
The Conversation,
Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
Long COVID leaves newly disabled people facing old barriers – a sociologist explains
Shelton Herald,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
USA Life Sciences Database,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Covid-19 Infection Increases Heart Disease Risk, Even In Mild Cases
Forbes,
As we enter the third year of the pandemic, it is becoming increasingly clear that Covid-19 infection impacts our health beyond…
In Conversation: Long COVID's cardiovascular implications
Medical News Today,
Millions of people worldwide live with long COVID, a condition characterized by symptoms of COVID-19 and other syndromes months…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Biz Wire Express,
GlobeNewswire 2022-03-07 In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
TMCnet.com,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Bluefield Daily Telegraph,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Stockwatch,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
MarketScreener,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
The Bakersfield Californian,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Yahoo! Finance USA,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Benzinga,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Morning Star,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
KULR 8,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
GlobeNewswire,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform
Biospace,
In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Crwe World,
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with SARS-CoV-2 (C…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Stockwatch,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Statera…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for
Bluefield Daily Telegraph,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Statera…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
MarketScreener,
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with SARS-CoV-2 (C…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for ...
KULR 8,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Statera…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Morning Star,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Statera…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Yahoo! Finance USA,
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with SARS-CoV-2 (C…
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
GlobeNewswire,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Statera…
Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Biz Wire Express,
GlobeNewswire 2022-03-02 Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul…
Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
TMCnet.com,
FORT COLLINS, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc.
CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Biospace,
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with SARS-CoV-2 (C…
News story from The Age on Friday 25 February 2022
The Age,
News story from Sydney Morning Herald on Friday 25 February 2022
Sydney Morning Herald,
The silent killer: Why medical research is fired up about inflammation
Brisbane Times,
Pinned to the noticeboard behind Dr Sarah Coombes’ desk at the bunker-like Sydney Ambulance Centre in Eveleigh is a dramatic…
News story from Western Australia Today on Friday 25 February 2022
Western Australia Today,
Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich Long COVID-19
Börse Express,
Quelle: IRW Press _ December 2008 - Weltweit erste Studie* zur Bewertung von bis zu 7.000 Plasmaproteinen bei Long-COVID-19-Patie…
IRW-News: Antisense Therapeutics Limited: Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich Long COVID-19
Aktien Check,
IRW-PRESS: Antisense Therapeutics Limited: Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich…
News story from Finanz Nachrichten on Thursday 24 February 2022
Finanz Nachrichten,
Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich Long COVID-19
Ariva,
- Weltweit erste Studie* zur Bewertung von bis zu 7.000 Plasmaproteinen bei Long-COVID-19-Patienten - Zusammenarbeit mit…
Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich Long COVID-19
Ad Hoc News,
Antisense Therapeutics: Strategische Zusammenarbeit mit US-Experten hinsichtlich Long COVID-19.
No sólo la covid puede ser persistente: "Es un proceso frecuente, también ocurre con la gripe"
NIUS,
Rafa Toledo: "El síndrome post-viral no es específico de la covid. Es un proceso normal, en infecciones virales o bacterianas…
100-million people globally with persistent symptoms? Two ‘long Covid’ stats, investigated
Witbank News,
The term “long Covid” is by now familiar for the symptoms many suffer months after infection with Covid-19.
UK data sheds light on long COVID: Groups at risk, Omicron, and more
Medical News Today,
Share on PinterestAccording to government data, the number of people with long COVID in the United Kingdom has been rising…
100-million people globally with persistent symptoms? Two ‘long Covid’ stats, investigated
Polity.org.za ,
The South African government has, as of 1 February 2022, relaxed its regulations to prevent the spread of Covid-19.
8 Reasons Why You Really Don't Want Omicron Right Now
Fatherly,
With Omicron wreaking havoc across the U.S., it seems like everyone is going to get COVID eventually.
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
IT News Online,
2022-02-02 BOSTON, Feb. 2, 2022 /PRNewswire/ -- Arcadia (arcadia.io), the leading population health management and health…
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
TMCnet.com,
BOSTON, Feb. 2, 2022 /PRNewswire/ -- Arcadia (arcadia.io), the leading population health management and health intelligence…
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
Ticker Tech,
Patients discharged for COVID-19 are 1.6 times more likely to die than a patient discharged for sepsis.
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
WAFB 9,
BOSTON, Feb. 2, 2022 /PRNewswire/ -- Arcadia (), the leading population health management and health intelligence platform…
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
South Carolina News Now,
BOSTON, Feb. 2, 2022 /PRNewswire/ -- Arcadia (arcadia.io), the leading population health management and health intelligence…
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
Yahoo! Finance USA,
Patients discharged for COVID-19 are 1.6 times more likely to die than a patient discharged for sepsis.
Arcadia Analysis of COVID-19 Hospital Patient Data Shows Higher Post-Discharge Mortality Rate Compared to Non-COVID Patients
KPVI,
BOSTON, Feb. 2, 2022 /PRNewswire/ -- Arcadia (arcadia.io), the leading population health management and health intelligence…